TITLE

New clinical guidelines say misconceptions have surrounded hormone therapy

AUTHOR(S)
Eggertson, Laura
PUB. DATE
March 2009
SOURCE
CMAJ: Canadian Medical Association Journal;3/3/2009, Vol. 180 Issue 5, p504
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the clinical guidelines released by the Society of Obstetricians and Gynaecologists of Canada which focus on the utilization of hormone therapy among menopause women. It reveals that the guidelines aim to address the misconceptions on the health risks associated with hormone therapy, such as stroke, heart attack and breast cancer. It was found that the guidelines were the Society's response to the result of the Women's Health Initiative study which considers hormone therapy as risk factors for the development of diseases among women. In addition, the guidelines recommend to address lifestyles that contribute to the development of cardiovascular diseases and cancer.
ACCESSION #
36872191

 

Related Articles

  • Hormone Therapy: The End of an Era.  // Annals of Internal Medicine;4/6/2004, Vol. 140 Issue 7, p539 

    Reports on the effects of hormone therapy in women. Increase in the risk of invasive breast cancer in the combined Estrogen plus Progestin replacement therapy; Focus of the Women's Health Initiative (WHI); Recommendation to avoid the use of postmenopausal combined hormone therapy to prevent any...

  • ACOG Guidance on Menopausal Symptoms.  // Clinician Reviews;Aug2015, Vol. 25 Issue 8, p48 

    The article offers the author's insights on the guidance issued by American College of Obstetricians and Gynecologists (ACOG) for vaginal and systemic hormone therapy (HT). Topics discussed include the role of HT as an effective treatment for menopausal vasomotor symptoms, the risk of...

  • Postmenopausal Hormone Use in Women with Acute Coronary Syndromes. Parsons, Elizabeth; Newby, L. Kristin; Bhapkar, Manjushri V.; Alexander, Karen P.; White, Harvey D.; Shah, Svati H.; Bushnell, Cheryl D.; Califf, Robert M. // Journal of Women's Health (15409996);Oct2004, Vol. 13 Issue 8, p863 

    Background: Recent trials reveal no benefit and possible harm from chronic hormone replacement therapy (HRT). Less is known about intermediate-term outcomes associated with HRT use in the setting of acute coronary syndromes (ACS). Methods: To examine the prevalence of HRT use and relationships...

  • Update on Menopause. Kaunitz, Andrew M. // Clinician Reviews;Aug2015, Vol. 25 Issue 8, p46 

    The article offers information on various aspects related to safe and effective usage of menopausal hormone therapy (HT). Topics discussed include the data from Women's Health Initiative (WHI) regarding the possible link of breast cancer and myocardial infarction (MI), the risk of HI for...

  • WHI extends follow-up of unopposed oestrogen trial. Brown, simon // Menopause International;Jun2011, Vol. 17 Issue 2, p37 

    The article reports that the Women's Health Initiative (WHI) trial of unopposed oestrogen (CEE) therapy in hysterectomized women has revealed higher risk of stroke and lower risk of hip fracture and possibly breast cancer in those randomly assigned to active treatment than those on placebo. WHI...

  • Menopausal Muddle. Park, Alice; Sifferlin, Alexandra // Time;8/5/2013, Vol. 182 Issue 6, p12 

    The article discusses estrogen therapy as of August 2013, focusing on a Yale University research study which estimates that 50,000 postmenopausal women between the ages of 50 and 59 may have died prematurely due to incomplete information about the dangers of hormone-replacement therapy (HRT).

  • Raised cancer risk remains for years after HRT stopped. Tanday, Sanjay // GP: General Practitioner;3/7/2008, p6 

    The article reports on the results of a U.S. study which reveals that women who have stopped taking oestrogen plus progesteron hormone replacement therapy could still be at risk of developing cancer. According to the Women's Health Initiative study, there is a 26 percent increased risk of breast...

  • National Osteoporosis Society's Position Statement on hormone replacement therapy in the prevention and treatment of osteoporosis. Bowring, C. E.; Francis, R. M. // Menopause International;Jun2011, Vol. 17 Issue 2, p63 

    Hormone replacement therapy (HRT) has been shown to increase bone density, reduce the risk of fracture and can successfully relieve menopausal symptoms. From a time when HRT was the major therapeutic option for the management of osteoporosis, women and their clinicians now have a range of...

  • The Cancer Causing Facts about "Hormone Pills" and Why Bio-Identical Hormone Therapies (BHRT) are a Safe Alternative.  // Townsend Letter for Doctors & Patients;Nov2005, Issue 268, p19 

    Focuses on the debate within the medical community regarding the potential side effects associated with synthetic hormone replacement therapies (HRT) versus the safety and efficacy of bio-identical or human-identical hormone therapies. Link of synthetic HRT with increased rates of breast and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics